by Matt Rust | Oct 11, 2018 | Commentary
The performance of the stock market today will undoubtedly catch the attention of the non-business media. So, prepare to see headlines such as “Stocks Sink” or “Stocks Take a Tumble” or “Interest Rates Rise While Stocks Fall” along with other “journalistic gems” of...
by Matt Rust | Jul 27, 2018 | Commentary
It is easy to describe the current political and economic environment as unique. After all we have a president who, regardless of your political stripes, is carrying out his duties in a way that has not been seen for quite a while. Concerns over internet privacy has...
by Matt Rust | Jul 2, 2018 | Commentary
Given the tremendous amount of political activity surrounding financial markets so far this year, it might be hard to believe that the S&P 500® Index is higher by 2.81% rather than down by a double-digit percentage. While stocks are lower from their recent higher...
by Matt Rust | Mar 27, 2018 | Commentary
The S&P 500 is down 8% over the last 9 days. This decline represents what we believe is a normal and healthy retest of the February lows. Stocks are quite oversold as we plumb our way back to those February levels. This suggests to us that there is little downside...
by Matt Rust | Mar 6, 2018 | Commentary
During the selloff which took place at the beginning of February we highlighted our view that volatility would persist for quite a while. Indeed, it has but we remind everyone that this level of volatility is more normal than the unprecedented period of calm which...
by Matt Rust | Feb 12, 2018 | Commentary
“Insulin is not a cure for diabetes; it is a treatment. It enables the diabetic to burn sufficient carbohydrates so that proteins and fats may be added to the diet in sufficient quantities to provide energy for the economic burdens of life.” -Federick Banting A...
